Lefamulin (CED0010609)

Record Information
Version1.0
Creation Date2026-04-14 19:06:04 UTC
Update Date2026-08-22 08:39:42 UTC
Accession NumberCHEM131732
Identification
Common NameLefamulin
ClassSmall Molecule
Description
Lefamulin is an organic compound with the formula C28H45NO5S. Lefamulin belongs to the diterpenoids, a subclass of prenol lipids within the organic compounds. With an average molecular weight of 507.73 g/mol, Lefamulin is a heavy molecule. It is found in healthcare, pharmaceuticals, and veterinary products as an antibacterial agent, with recorded exposure routes including oral and intravenous administration. Regarding its mechanism of action, it acts as a binder and inhibitor of the large ribosomal subunit protein uL22 (rplV).
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC28H45NO5S
Average Molecular Mass507.730 g/mol
Monoisotopic Mass507.302 g/mol
CAS Registry Number1061337-51-6
IUPAC NameNot Available
Traditional NameNot Available
SMILES[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O
InChI IdentifierInChI=1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16?,17-,18+,20+,21+,22+,24-,25-,26+,27-,28-/m0/s1
InChI KeyKPVIXBKIJXZQJX-CSOZIWFHSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
1605.0Log mg/kg[900:2900]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
347AntibacterialsHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureAdenylate cyclase type 1P19754Bos taurusPredicted (SEA)3.42537
Click to view 3D structureTransient receptor potential cation channel subfamily M member 2E9PTA2Rattus norvegicusPredicted (SEA)11.2881
Click to view 3D structureNuclear receptor subfamily 1 group I member 2Q9R1A7Rattus norvegicusPredicted (SEA)15.492
Glucocorticoid receptor structureClick to view 3D structureGlucocorticoid receptorP04150HumansPredicted (SEA)3611.81
DNA topoisomerase 2-alpha structureClick to view 3D structureDNA topoisomerase 2-alphaP11388HumansPredicted (SEA)754.67
Mineralocorticoid receptor structureClick to view 3D structureMineralocorticoid receptorP08235HumansPredicted (SEA)2762.71
Androgen receptor structureClick to view 3D structureAndrogen receptorP10275HumansPredicted (SEA)4472.83
Click to view 3D structureGlucocorticoid receptorP06536Rattus norvegicusPredicted (SEA)334.362
Tubulin--tyrosine ligase structureClick to view 3D structureTubulin--tyrosine ligaseQ8NG68HumansPredicted (SEA)7.16213
Click to view 3D structureAndrogen receptorP15207Rattus norvegicusPredicted (SEA)1191.95
Tyrosine-protein phosphatase non-receptor type 1 structureClick to view 3D structureTyrosine-protein phosphatase non-receptor type 1P18031HumansPredicted (SEA)4054.31
Phospholipase A2, membrane associated structureClick to view 3D structurePhospholipase A2, membrane associatedP14555HumansPredicted (SEA)2460.04
Click to view 3D structureGlycogen [starch] synthase, liverP54840HumansPredicted (SEA)35.5771
Click to view 3D structureGlucose-6-phosphatase catalytic subunit 1P43428Rattus norvegicusPredicted (SEA)35.5771
Click to view 3D structureProgesterone receptorQ690N0Bos taurusPredicted (SEA)266.789
Progesterone receptor structureClick to view 3D structureProgesterone receptorP06401HumansPredicted (SEA)4859.5
Corticosteroid-binding globulin structureClick to view 3D structureCorticosteroid-binding globulinP08185HumansPredicted (SEA)76.2922
Sex hormone-binding globulin structureClick to view 3D structureSex hormone-binding globulinP04278HumansPredicted (SEA)151.417
Click to view 3D structure11-beta-hydroxysteroid dehydrogenase type 2P80365HumansPredicted (SEA)1011.34
Solute carrier family 2, facilitated glucose transporter member 1 structureClick to view 3D structureSolute carrier family 2, facilitated glucose transporter member 1P11166HumansPredicted (SEA)5176.35
11-beta-hydroxysteroid dehydrogenase 1 structureClick to view 3D structure11-beta-hydroxysteroid dehydrogenase 1P28845HumansPredicted (SEA)3900.56
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)7350.45
Protein deacetylase HDAC6 structureClick to view 3D structureProtein deacetylase HDAC6Q9UBN7HumansPredicted (SEA)7458.5
Click to view 3D structureGlucocorticoid receptorP06537Mus musculusPredicted (SEA)115.528
Click to view 3D structureTyrosine aminotransferaseP04694Rattus norvegicusPredicted (SEA)19.6959
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available